ADAR1 Capital Management »

Pmv Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $17k 10k 1.70

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Vanguard Group
Acadian Asset Management
Partner Fund Management
BML Capital Management
BlackRock
BlackRock
Citadel Advisors
D. E. Shaw & Co
Goldman Sachs Group
Jacobs Levy Equity Management
Personal Cfo Solutions

View all funds holding Pmv Pharmaceuticals